TDC
DVAX

Thompson Davis & Co’s Dynavax Technologies DVAX Stock Holding History

Thompson Davis & Co’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-250
Closed -$4K – 728
2018
Q2 		$4K Hold
250
– – 0.01% 532
2018
Q1 		$5K Buy
+250
New +$4.32K 0.01% 476
2017
Q4 		– Sell
-375
Closed -$8K – 786
2017
Q3 		$8K Buy
+375
New +$5.93K 0.01% 738

Other funds holding DVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Thompson Davis & Co's DVAX Position: Q3 2018 in Review

Thompson Davis & Co sold out of Dynavax Technologies (DVAX) in Q3 2018, closing a stake of 250 shares — an estimated $4K sold.

Thompson Davis & Co first reported a position in DVAX in Q3 2017 and held it in 3 quarters. The position peaked at $8K in Q3 2017. 150 funds tracked by Wall St. Rank hold DVAX as of Q3 2018.

  • Thompson Davis & Co reported no remaining Dynavax Technologies position as of Q3 2018 after selling out during the quarter.
  • Thompson Davis & Co sold 250 Dynavax Technologies shares in Q3 2018, an estimated $4K.
  • Thompson Davis & Co first reported a position in Dynavax Technologies in Q3 2017 and held it in 3 quarters.
  • Thompson Davis & Co's Dynavax Technologies position peaked at $8K in Q3 2017.
  • 150 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.